SII Chief Executive Officer Adar Poonawalla told NDTV that the vaccine is being developed in collaboration with Novavax. Poonawalla further said that the vaccine will be specific to the BA5 sub-variant of Omicron.
Copyright © 2024 | WordPress Theme by MH Themes